STRENSIQ
As listed in the register: STRENSIQ 40 mg/ml, solution injectable
40 mg · solution injectable
- Prescription only
- Active substance
- Asfotase Alfa
- Made by
- ALEXION EUROPE
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
Mediclarum has not yet retrieved and stored the official label for this product, so none of its text is shown here. Open the official leaflet
How it works
From the US prescribing label for the same active substance (STRENSIQ). It describes the substance, not this exact product.
HPP is caused by a deficiency in TNSALP enzyme activity, which leads to elevations in several TNSALP substrates, including inorganic pyrophosphate (PPi).
TNSALP is a metallo-enzyme that catalyzes the hydrolysis of phosphomonoesters with release of inorganic phosphate and alcohol.
Quoted from the prescribing label, sections “Mechanism of Action” and “Pharmacokinetics”. DailyMed · 2025-12-12
Safety of the active substance
From the US prescribing label for the same active substance (STRENSIQ). It describes the substance, not this exact product.
WARNING: HYPERSENSITIVITY REACTIONS INCLUDING ANAPHYLAXIS Patients treated with enzyme replacement therapies have experienced life-threatening hypersensitivity reactions, including anaphylaxis.
The most common adverse reactions reported were injection site reactions (63%).
Quoted from the US prescribing label for the same active substance. Your own pack’s leaflet is the authority for your product. DailyMed
Same active substance, strength and form in other countries
Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.
Medicine passport: one printable page to show a pharmacist abroad
United StatesNo exact match for this strength and form
European UnionNo exact match for this strength and form
CanadaNo exact match for this strength and form
Netherlands1 matching products
Details
| Made by | ALEXION EUROPE |
|---|---|
| Active substance | Asfotase Alfa |
| Strength | 40 mg |
| Form | solution injectable |
| Route | sous-cutanée |
| Dispensing (as stated by the register) | médicament nécessitant une surveillance particulière pendant le traitement · prescription hospitalière · liste I |
| Marketed | Yes, according to the register |
| Reinforced monitoring | Yes — under reinforced monitoring, according to the register |
| Authorisation procedure | Procédure centralisée |
| EU number | EU/1/15/1015 |
| Name in the register | STRENSIQ 40 mg/ml, solution injectable |
| Packs | 12 flacon(s) en verre de 0,45 ml · 12 flacon(s) en verre de 0,7 ml · 12 flacon(s) en verre de 1 ml |
| CIS | 64450234 |
| CIP13 | 3400930031094 |
| CIP13 | 3400930031124 |
| CIP13 | 3400930031148 |
Source: Base de données publique des médicaments · 2026-09-30 · not reviewed by a clinician
Source : Base de données publique des médicaments (ANSM / Ministère de la Santé), sous Licence Ouverte. Reuse terms: Licence Ouverte / Open Licence (Etalab).
Other strengths and forms
2 products are sold under this name. Grouped by form; a number on a strength means several companies make it.
- solution injectable2 products
- 40 mg
- 100 mg
Same active substance
These contain the same substance. That does not mean one can replace another — ask a pharmacist.